Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland.
Team Novo Nordisk Professional Cycling Team Atlanta GA USA.
Endocrinol Diabetes Metab. 2020 Aug 29;4(1):e00180. doi: 10.1002/edm2.180. eCollection 2021 Jan.
The COVID-19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person-to-person contact is to offer remote services (telemedicine). This study aimed to (1) gather real-time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies.
An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open-access web-based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA.
There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty-two per cent reported no fundamental change in their medical follow-up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty-eight per cent received remote care through telephone (72%) or video-calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA, was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA > 9% rated telemedicine not useful compared to those with lower HbA while 20% of females with an HbA > 9% rated it not useful (χ = 14.2, = .0016).
Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
COVID-19 大流行迫使人们重新考虑医疗保健的提供方式。一种提供护理而避免不必要的人际接触的潜在方法是提供远程服务(远程医疗)。本研究旨在:(1)收集有关 1 型糖尿病患者使用和感知远程医疗的实时信息;(2)评估面临的挑战,例如医疗保健和/或医疗用品获取受限。
2020 年 3 月 24 日至 5 月 5 日,使用开放获取的网络平台广泛分发匿名问卷。使用描述性方法分析数据,并根据年龄、性别和 HbA 分层结果。
来自 89 个国家的 7477 名参与者对调查做出了回应。全球范围内,由于取消了与医疗保健提供者的物理预约,30%的人报告说大流行影响了他们的医疗保健获取。32%的人报告在这段时间内他们的医疗随访没有根本变化,9%的人表示在研究期间没有与医生进行任何个人接触。28%的人通过电话(72%)或视频电话(28%)接受远程护理。其中,86%的人认为远程预约有用,75%的人计划在未来进行远程预约。HbA 所指示的血糖控制与对远程医疗的积极看法呈正相关。在男性中,45%HbA>9%的受访者认为远程医疗没有用,而 HbA 较低的男性中只有 20%的人认为远程医疗没有用(χ=14.2,=0.0016)。
远程预约在 1 型糖尿病患者中大多被认为是积极的,大多数(75%)人表示他们会考虑在大流行后进行远程预约。年龄和教育程度似乎不会影响对远程医疗的看法,而血糖控制不佳,特别是在男性中,似乎会对看法产生负面影响。